B12 and Cathflo activase drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take B12 (cobalamin) and Cathflo activase (alteplase). Common drug interactions include fall among females and dizziness among males.
The phase IV clinical study analyzes what interactions people have when they take B12 and Cathflo activase. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is B12?
B12 has active ingredients of cobalamin. It is often used in vitamin b12 deficiency. eHealthMe is studying from 121,894 B12 users. Check the latest studies of B12.
What is Cathflo activase?
Cathflo activase has active ingredients of alteplase. eHealthMe is studying from 1,469 Cathflo activase users. Check the latest studies of Cathflo activase.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
37 people who take B12 and Cathflo activase together, and have interactions are studied.

What are the common drug interactions of B12 and Cathflo Activase, by gender? *:
female:
- Fall
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Blood pressure fluctuation
- Infusion related reaction
- Catheter site infection (infection at the site of insertion)
- Chest discomfort
- Chills (felling of cold)
- Erythema (redness of the skin)
male:
- Dizziness
- Dehydration (dryness resulting from the removal of water)
- Blood pressure decreased
- Cardiac disorder
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Cough
- Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)
- Hemiparesis (weakness on one side of the body)
- Hemiplegia (paralysis of one side of the body)
- Hypertension (high blood pressure)
What are the common drug interactions of B12 and Cathflo Activase, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Chest pain
- Pruritus (severe itching of the skin)
- Urticaria (rash of round, red welts on the skin that itch intensely)
20-29:
n/a
30-39:
- Blood pressure fluctuation
- Fall
- Headache (pain in head)
- Infusion related reaction
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Catheter site infection (infection at the site of insertion)
- Chest discomfort
- Chills (felling of cold)
- Erythema (redness of the skin)
40-49:
n/a
50-59:
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Death
- Oedema peripheral (superficial swelling)
- Tenderness (pain or discomfort when an affected area is touched)
- Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
- Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls)
- Weight increased
60+:
- Dyspnoea (difficult or laboured respiration)
- Dehydration (dryness resulting from the removal of water)
- Dysphonia (speech disorder attributable to a disorder of phonation)
- Gait disturbance
- Hospitalisation
- Ligament sprain (ligament stretched)
- Lung disorder (lung disease)
- Pericardial effusion (fluid around the heart)
- Pleural effusion (water on the lungs)
- Pneumonia
What are the existing conditions these people have? *
- Nausea (feeling of having an urge to vomit): 8 people, 21.62%
- Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 6 people, 16.22%
- Pain: 6 people, 16.22%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 10.81%
- Device Occlusion: 4 people, 10.81%
- Nausea And Vomiting: 4 people, 10.81%
- High Blood Pressure: 4 people, 10.81%
- Hypokalemia (low potassium): 4 people, 10.81%
- Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 3 people, 8.11%
- Chest Pain: 3 people, 8.11%
* Approximation only. Some reports may have incomplete information.
Do you take B12 and Cathflo activase?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- B12 (121,894 reports)
- Cathflo activase (1,469 reports)
Browse all drug interactions of B12 and Cathflo activase:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of B12:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cathflo activase:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between B12 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cathflo activase and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on cobalamin and alteplase (the active ingredients of B12 and Cathflo activase, respectively), and B12 and Cathflo activase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sandostatin Lar cause Glucose Urine Present? - 4 seconds ago
- Tendonitis and Rashes - 14 seconds ago
- Could Remicade cause Intraocular Melanoma? - 15 seconds ago
- Could Myrbetriq cause Leukopenia? - 37 seconds ago
- Optic Neuropathy and drugs of ingredients of metoprolol tartrate - 48 seconds ago
- Drug interactions of Moxifloxacin and Nevirapine - 49 seconds ago
- Bone Density Decreased and drugs of ingredients of bevacizumab - 55 seconds ago
- Could Mycophenolate Mofetil cause Cutaneous Vasculitis? - a minute ago
- Bipolar Disorder and Fainting - a minute ago
- Osteoarthritis and drugs of ingredients of cabazitaxel - a minute ago